2. UroToday Home
  3. Video Lectures

Clinical Trials For My Patients - Prostate Cancer Videos

LuTectomy, a Single-Arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Radical Prostatectomy - Declan Murphy & Renu Eapen
July 5, 2022
Details
Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence - UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 22, 2022
Details
Sabizabulin in Phase 1b/2 Clinical Trials of Men With Metastatic Castration-Resistant Prostate Cancer Who Progressed on Androgen Receptor-Targeting Agents - Mark Markowski
April 14, 2022
Details
Darolutamide plus ADT in Metastatic Hormone-Sensitive Prostate Cancer - The ARASEC Trial - Neal Shore
March 27, 2022
Details
Real-World Understanding of the Prevalence of Potentially Targetable DNA Damage Repair Alterations – The PROMISE Registry – Heather Cheng
March 10, 2022
Details
ARANOTE - Darolutamide in Addition to ADT Vs. ADT in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) - Fred Saad
March 10, 2022
Details
Sabizabulin in Men with Metastatic Castration Resistant Prostate Cancer - Mark Markowski
October 31, 2021
Details
A Trial of VERU-100 for the Treatment of Advanced Prostate Cancer – Ronald Tutrone
October 31, 2021
Details
PSMAfore Trial - Evaluating 177Lu-PSMA-617 in Chemotherapy-Naïve mCRPC Patients – Michael Morris
October 15, 2021
Details
Evaluating the Efficacy of Sabizabulin in The Treatment of Metastatic Castration-Resistant Prostate Cancer – Robert Dreicer
September 28, 2021
Details
Single Priming Dose of 177Lu-PSMA-617 Followed by Pembrolizumab in mCRPC in a Phase 1b Trial - Rahul Aggarwal
August 27, 2021
Details
Differences in the Pattern of and the Response to Treatment Not Just Race - Elisabeth Heath
June 27, 2021
Details
Evaluating the Benefit of Rucaparib and Enzalutamide Combination Therapy Vs. Enzalutamide Alone for the Treatment of mCRPC - the Phase III CASPAR Trial - Arpit Rao
March 8, 2021
Details
Intensive Androgen Deprivation in High-Risk Biochemically Recurrent Prostate Cancer Patients - Alliance Foundation Trial (AFT19) - Rahul Aggarwal
February 23, 2021
Details
Implementing Prostate Cancer Working Group 3 Criteria in Clinical Trials- Michael Morris and Lawrence Schwartz
February 25, 2020
Details
The DORA Trial, Comparing Overall Survival in Patients Treated with Docetaxel vs. Docetaxel plus Radium-223 - Michael Morris
November 20, 2019
Details
Count Me In! The Metastatic Prostate Cancer Project - Eliezer Van Allen
September 16, 2019
Details
A Study Evaluating Optimal Use of Radioactive Drugs for Prostate Cancer Therapy - Misha Beltran
August 2, 2019
Details
Current Landscape of Prostate Cancer Clinical Trials - Alliance Cooperative Group - Michael J. Morris
July 30, 2019
Details
STARTAR Trial: Systemic Therapy in Salvage Setting for Prostate Cancer- Tian Zhang
November 28, 2018
Details
email news signup